dr. fakhri on selecting the optimal treatment in cll
Published 4 years ago • 795 plays • Length 1:54Download video MP4
Download video MP3
Similar videos
-
1:25
dr. fakhri on ongoing clinical trials in cll
-
1:45
dr. fakhri on ibrutinib-containing regimens in cll
-
1:21
dr. fakhri on the use of pi3k inhibitors in relapsed/refractory cll
-
0:44
dr. furman on frontline treatment selection in cll
-
2:12
dr. fakhri on the use of carfilzomib in multiple myeloma
-
1:51
dr. smith on frontline treatment considerations in cll
-
9:03
up-front ibrutinib versus fcr for patients with cll
-
1:58
dr. shadman on fixed durations of treatment in cll
-
7:31
maintenance treatment in chronic lymphocytic leukemia
-
7:34
safety and efficacy of cll treatments
-
8:09
novel treatment approaches to relapsed/refractory cll
-
2:11
dr. awan on time-limited treatments in cll
-
4:02
managing ibrutinib toxicity in cll
-
0:32
patient selection for ctcl
-
1:40
dr. leslie on real-world outcomes of patients with cll treated with acalabrutinib
-
3:02
what to know about the new cholesterol guidelines
-
1:22
dr. ghosh on unanswered questions with btk inhibitors in cll/sll
-
3:49
guidelines, rate control, and exercise in hf
-
1:12
patient-specific factors to consider in cll treatment management